More Business Wire
View Older Stories View Newer Stories-
AI Investment Boom Across the UK is Fuelled More by Fear of Missing out Than Actual Results, According to Expereo
-
AULUMU Launches G05 Pro Multi-Function Mag Kickstand
-
Krisp Names Graham Brown Chief Growth Officer for Europe and Africa
-
Teledyne Gas and Flame Detection Helps Maritime Operators Address New IMO Safety Recommendations
-
KBRA Releases Research – European Fibre ABS: From Build-out to Securitisation
-
Everbridge Expands Presence in Germany with New Munich Office
-
Stallergenes Greer Invests More Than €125 Million in France
-
ICL Group Announces Launch of Senior Notes Offering
-
Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience
-
Pwrteams Begins Operating Under the Nortal Brand
-
58% of banks still relying on manual adverse media searches, Ripjar finds
-
Datavault AI Signs $2.0 Billion Structured Financing Term Sheet With Exclusive Global Tokenization Mandate
-
Blue Language Labs Emerges from Stealth to Launch the Coordination Layer for AI Agents That Do Real Business
-
3D Investment Releases White Paper Presentation, Manga (Comic), and Dedicated Website to Call On Shareholders to Vote “AGAINST” Toho HD’s Proposed Poison Pill Invocation at the June AGM
-
Winamp Group Completes Debt Restructuring, Executes Significant Debt Repayment and Improves Its Financial Profile
-
€900M European Consulting and Technology Leader Magellan Expands Into UK Market Following Strategic Acquisition of Transport and Mobility Giant MeTS
-
Corient Completes Acquisitions of Stonehage Fleming and Stanhope Capital Group; Global Assets Surpass US$500 Billion
-
DDN Advances Secure AI Factories with AI-Native Data Intelligence Infrastructure at NVIDIA GTC Taipei at COMPUTEX 2026
-
New Report From King: Mobile Games Sector Is Strategic Growth Driver for Europe, Contributing €6BN and Supporting 63,000+ Jobs
-
Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million
-
Autobrains and Uber to Launch Agentic AI Robotaxi Program in Munich built on NVIDIA DRIVE Hyperion
-
Synera Advances AI Agents for Design and Engineering Simulation with NVIDIA
-
Cadence Unveils Industry’s First Fully Autonomous Virtual Engineer for Chip Design, powered by NVIDIA
-
HPE Introduces CPU Server with NVIDIA Vera CPU, Purpose-built for Agentic AI
-
Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
-
Invisix Raises €20M Seed Round to Bring Soft X-Ray Metrology to AI-Era Chip Manufacturing
-
Nidec Announces Glass Lewis’s Report Recommending Votes in Favor of All Company Proposals at Nidec’s 53rd Regular General Meeting of Shareholders
-
Morse Micro Announces MM8108-M20 High-Power Wi-Fi HaLow Module to Accelerate Long-Range IoT Adoption
-
Power Integrations Unveils Space-Saving, Ultra-Slim Auxiliary PSU Reference Designs for NVIDIA Kyber 800 VDC AI Data Center
-
Ventiva Partners with ASUS to Explore Next-Generation Thermal Architectures for Compact AI Computing Systems
-
FPT and UOB Sign MoU to Advance AI, Technology Transformation and Financial Innovation
-
Mobvista (1860.HK) Delivers Solid 2026 Q1 Performance Fueled by AI-Driven Advertising
-
Best’s Market Segment Report: Japan Life Insurers’ Use of Reinsurance More Than Doubled Since 2020
-
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Total Sales and Shipments of EAI Robots Reached 69 Units in May, a New Record, Exceeding the Combined Total for the Months o
-
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMON
-
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
-
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
-
Kelonia Therapeutics Presents Updated First-in-Human Data from Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
-
ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
-
Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting
-
BW LPG Enters Into Agreement for Eight 90’cbm Panamax Newbuildings with Hyundai Heavy Industries
-
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
-
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
-
Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026
-
Global Real Assets Trust Reports Q1 2026 Results
-
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
-
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
-
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
-
Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
-
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in P
